Uncategorized

Lantern Pharma is Changing How We Think About Drug Discovery

Before 2024, Lantern Pharma (NASDAQ:LTRN) was relatively unnoticed in the biotech sector. It was merely a nano-cap biotech stock that was indistinguishable from a very crowded pool of other low-cap stocks vying...
Most Popular